alphaveBALPHARMA₹105.50

Bal Pharma Limited

₹ CrorePeersALPA KREBSBIO NATCAPSUQ VINEETLAB NECLIFE AAREYDRUGS BIOFILCHEM MANGALAMMcap ₹168 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	61.6	71.0	76.8	76.8
+ Capital Work-in-Progress	0.5	2.8	7.4	7.4
+ Goodwill	3.8	3.8	3.8	3.8
+ Other Intangibles	11.4	12.0	13.4	13.4
+ Long-term Loans	0.1	0.0	0.0	0.0
+ Other Non-current Financial Assets	2.7	7.1	8.1	8.1
Non-current Financial Assets	2.8	7.1	8.1	8.1
+ Deferred Tax Assets	2.4	0.4	0.8	0.8
+ Other Non-current Assets	2.9	3.7	3.0	3.0
Total Non-current Assets	85.4	100.8	113.3	113.3
Current Assets
+ Inventories	87.8	103.0	116.4	116.4
+ Current Investments	6.8	2.5	2.1	2.1
+ Trade Receivables	99.6	92.4	93.6	93.6
+ Cash & Cash Equivalents	4.2	1.8	2.3	2.3
+ Other Bank Balances	9.1	6.3	1.2	1.2
+ Short-term Loans	1.4	1.1	0.0	0.0
+ Other Current Financial Assets	1.0	1.3	6.5	6.5
Current Financial Assets	122.1	105.4	105.7	105.7
+ Other Current Assets	25.0	25.5	40.0	40.0
Total Current Assets	235.0	234.9	262.2	262.2
Total Assets	320.4	335.7	375.5	375.5
Equity
+ Equity Share Capital	15.8	15.9	15.9	15.9
+ Other Equity / Reserves	53.5	61.5	66.3	66.3
Equity — Owners of Parent	69.3	77.4	82.2	82.2
+ Minority Interest	-0.0	-0.0	0.0	0.0
Total Equity	69.3	77.4	82.3	82.3
Liabilities
+ Borrowings — Non-current	36.4	31.4	31.9	31.9
+ Other Non-current Financial Liab	1.8	1.7	6.0	6.0
Non-current Financial Liabilities	38.2	33.1	37.9	37.9
+ Provisions — Non-current	5.1	5.6	6.2	6.2
+ Deferred Tax Liabilities	4.0	0.0	0.0	0.0
Non-current Liabilities	47.2	38.8	44.1	44.1
+ Borrowings — Current	103.3	119.0	127.6	127.6
+ Trade Payables	78.3	81.7	89.0	89.0
+ Other Current Financial Liab	9.3	10.7	24.6	24.6
Current Financial Liabilities	190.9	211.4	241.2	241.2
+ Provisions — Current	0.9	1.2	0.8	0.8
+ Current Tax Liabilities	2.2	0.0	0.0	0.0
+ Other Current Liabilities	9.8	6.9	7.2	7.2
Current Liabilities	203.9	219.5	249.2	249.2
Total Liabilities	251.1	258.3	293.3	293.3
Total Equity & Liabilities	320.4	335.7	375.5	375.5
Assets — additional as-filed lines
+ Current Tax Assets	0.1	1.0	0.1	0.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.0	0.4	0.4
+ Dues to Other Creditors — Current	—	81.7	88.6	88.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.